Jyong Biotech Ltd. (MENS)

Jyong Biotech Ltd. (MENS) is a science-driven biotechnology company based in Taiwan that develops and plans to commercialize plant-derived drugs. Its work focuses initially on urological conditions, particularly men's health.

The company's lead candidates are botanical drug products intended to treat benign prostatic hyperplasia and lower urinary tract symptoms, and it has pursued clinical development in the United States, Taiwan and other markets. Jyong Biotech's approach is to identify active plant extracts, standardize them as pharmaceutical products and take them through regulatory approval pathways for botanical drugs.